With respect to colorectal cancer (CRC), we demonstrated, for the first time, upregulation of SPRY2 in CRC [13] and inflammatory bowel disease (IBD) [14] along with an oncogenic role of SPRY2 in CRC [15]. This evidence concerns the gene SPRY2 and colorectal cancer.